Stock listing

OTC:TGRP TRON Group Inc. Stock

Follow TRON Group Inc. into a list and get an email when it puts out news.

Share price · OTC:TGRP

$0.038 USD +0.005 (+15.2%)

Close on Oct 12, 2026

Ticker: OTC:TGRP
Asset type: Stock
Exchange: OTC
Currency: USD

Latest news

AACR 2025 Abstract PS5-07-23

Apr 23, 2026

Alchem Announces Poster Presentation on its AD=229 Program at Society for Neuroscience 2025 Conference

Dec 3, 2025

Dr. Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025

Oct 20, 2025

ESMO Abstract “1709MO - Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)”

Oct 13, 2025

Nanopharmaceutics Announces Presentation of National Cancer Institute sponsored Phase I Study with Triapine at ESMO 2025

Sep 10, 2025

Issued by another party

Nanopharmaceutics Announces End of Patient Recruitment for NCI Phase II Study with Triapine for Neuroendocrine Tumors

Jul 18, 2025

Issued by another party

Nanopharmaceutics Inc. Announces Initiation of Clinical Study of Triapine + Radiation for Glioblastoma or Astrocytoma

Apr 1, 2025

TRON Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

Apr 1, 2025

PRX-3140, a 5-HT4 Agonist and Sigma-1 Agonist/Antag., Modulates Glucocorticoid Insulin Suppression and Cortisol Levels

Dec 12, 2024

Nanopharmaceutics Announces Initiation of Clinical Study of Oral Tetrathiomolybdate Capsules in Breast Cancer Patients

Oct 11, 2024

All TRON Group Inc. news

TRON Group Inc. on 6ix

News releases: 3 in the last 12 months · 20 in all · newest Apr 23, 2026 · oldest 2016

Log in to ask 6ix AI your own questions about TRON Group Inc.